Abata Therapeutics
Sandy (Chaves) Lazzari has extensive experience in human resources, holding leadership roles in various companies such as Abata Therapeutics, PlateletBio, Emulate, Inc., Kala Pharmaceuticals, OvaScience, Quanterix, EMD Millipore, Hill Holliday, and Avid Technology, Inc. Sandy has demonstrated expertise in talent acquisition, organizational development, HR strategy, and global operations throughout their career.
Sandy (Chaves) Lazzari holds a Bachelor of Science in Business Management with a dual concentration in Business and Psychology from Southern New Hampshire University. Sandy also obtained a Masters Certificate in Human Resources Management/Personnel Administration, General from the same university. In 2021, they completed an Executive Certificate in Executive Education Women's Leadership Program from Yale University. Additionally, Sandy holds multiple certifications such as Situational Leadership Certified Trainer from The Center for Leadership Studies in 2019 and Human Capital Strategist from the Human Capital Institute (HCI) in 2010, among others.
This person is not in any teams
Abata Therapeutics
1 followers
Abata Therapeutics is bringing an entirely new approach to the treatment of autoimmune disease by engineering Tregs as targeted therapies that stop immune-mediated destruction, restore homeostasis – a state of harmony – and promote repair in the affected tissues. In addition to their lead program in progressive MS, Abata has early programs in Type 1 Diabetes (T1D) and inclusion body myositis (IBM). They bring together industry experts and deeply engaged pioneers in Treg biology, T cell receptor and antigen discovery, disease pathogenesis, and molecular and imaging biomarkers.